Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. | J Cancer Res Clin Oncol | 2023 | 36376617 | PubTator, text mining | PubMed |
| Familial acute aortic dissection associated with a novel ACTA2 germline variant. | Virchows Arch | 2023 | 35896809 | PubTator, text mining | PubMed |
| Immunomodulatory Role of Microelements in COVID-19 Outcome: a Relationship with Nutritional Status. | Biol Trace Elem Res | 2023 | 35668151 | PubTator, text mining | PubMed |
| A Novel SPTA1 Mutation in a Patient with Hereditary Spherocytosis without a Family History and Coexisting Gilbert's Syndrome. | Intern Med | 2023 | 35650129 | PubTator, text mining | PubMed |
| Calculated parameters for the diagnosis of Wilson disease. | Singapore Med J | 2023 | 35139628 | PubTator, text mining | PubMed |
| Biological potential of copper complexes: a review. | Turk J Chem | 2022 | 37720617 | PubTator, text mining | PubMed |
| Autosomal Recessive ACTG2-Related Visceral Myopathy in Brothers. | JPGN Rep | 2022 | 37168481 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related genes in immune infiltration in ischemic stroke. | Front Neurol | 2022 | 36818726 | PubTator, text mining | PubMed |
| A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma. | Front Oncol | 2022 | 36776374 | PubTator, text mining | PubMed |
| Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma. | Front Immunol | 2022 | 36733399 | PubTator, text mining | PubMed |
| A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer. | Front Pharmacol | 2022 | 36699089 | PubTator, text mining | PubMed |
| Case report: Motor neuron disease phenotype associated with symptomatic copper deficiency: Challenging diagnosis and treatment. | Front Neurol | 2022 | 36686537 | PubTator, text mining | PubMed |
| An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma. | Front Genet | 2022 | 36685880 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma. | Front Immunol | 2022 | 36685508 | PubTator, text mining | PubMed |
| Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer. | Front Surg | 2022 | 36684237 | PubTator, text mining | PubMed |
| Mechanism and effects of STING-IFN-I pathway on nociception: A narrative review. | Front Mol Neurosci | 2022 | 36683857 | PubTator, text mining | PubMed |
| Ataxia in Neurometabolic Disorders. | Metabolites | 2022 | 36676973 | PubTator, text mining | PubMed |
| Biological Effects of Human Exposure to Environmental Cadmium. | Biomolecules | 2022 | 36671421 | PubTator, text mining | PubMed |
| Molecular typing and prognostic model of lung adenocarcinoma based on cuprotosis-related lncRNAs. | J Thorac Dis | 2022 | 36647499 | PubTator, text mining | PubMed |
| A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review. | Medicine (Baltimore) | 2022 | 36626411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=31